Fluocinolone acetonide vitreous insert for chronic diabetic macular oedema: a systematic review with meta-analysis of real-world experience

We conducted a meta-analysis of real-world studies on the 0.19 mg Fluocinolone Acetonide (FAc) intravitreal implant for chronic diabetic macular oedema (DMO), comparing these findings with the Fluocinolone Acetonide for Diabetic Macular Edema (FAME) study. The primary outcome was mean change of best...

Descripción completa

Detalles Bibliográficos
Autores principales: Fallico, Matteo, Maugeri, Andrea, Lotery, Andrew, Longo, Antonio, Bonfiglio, Vincenza, Russo, Andrea, Avitabile, Teresio, Furino, Claudio, Cennamo, Gilda, Barchitta, Martina, Agodi, Antonella, Marolo, Paola, Ventre, Luca, Caselgrandi, Paolo, Reibaldi, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910468/
https://www.ncbi.nlm.nih.gov/pubmed/33637841
http://dx.doi.org/10.1038/s41598-021-84362-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910468/
https://www.ncbi.nlm.nih.gov/pubmed/33637841
http://dx.doi.org/10.1038/s41598-021-84362-y

Ejemplares similares